• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Relationship between estrogen receptor values and clinical data in predicting the response to endocrine therapy for patients with advanced breast cancer.

作者信息

Byar D P, Sears M E, McGuire W L

出版信息

Eur J Cancer (1965). 1979 Mar;15(3):299-310. doi: 10.1016/0014-2964(79)90041-0.

DOI:10.1016/0014-2964(79)90041-0
PMID:446512
Abstract
摘要

相似文献

1
Relationship between estrogen receptor values and clinical data in predicting the response to endocrine therapy for patients with advanced breast cancer.雌激素受体值与晚期乳腺癌患者内分泌治疗反应预测中的临床数据之间的关系。
Eur J Cancer (1965). 1979 Mar;15(3):299-310. doi: 10.1016/0014-2964(79)90041-0.
2
Clinical predictive criteria for response to endocrine treatment and the receptor status.内分泌治疗反应及受体状态的临床预测标准。
Recent Results Cancer Res. 1980;71:26-9. doi: 10.1007/978-3-642-81406-8_7.
3
The variability of estrogen receptors in metastatic breast cancer.转移性乳腺癌中雌激素受体的变异性
Am J Surg. 1979 Feb;137(2):260-2. doi: 10.1016/0002-9610(79)90159-4.
4
Relationship between estrogen-receptor proteins and response to chemotherapy in breast cancer.雌激素受体蛋白与乳腺癌化疗反应之间的关系
Cancer Treat Rep. 1984 Apr;68(4):573-6.
5
Quantitative estrogen receptor analyses: the response to endocrine and cytotoxic chemotherapy in human breast cancer and the disease-free interval.定量雌激素受体分析：人类乳腺癌对内分泌和细胞毒性化疗的反应及无病生存期。
Cancer. 1980 Dec 15;46(12 Suppl):2829-34. doi: 10.1002/1097-0142(19801215)46:12+<2829::aid-cncr2820461419>3.0.co;2-m.
6
Clinical applications of receptor measurements in breast cancer.受体测量在乳腺癌中的临床应用
Br J Cancer. 1980 Jan;41(1):136-9. doi: 10.1038/bjc.1980.16.
7
Endocrine therapy of advanced breast cancer.晚期乳腺癌的内分泌治疗
Acta Oncol. 1988;27(6A):721-8. doi: 10.3109/02841868809091775.
8
Estrogen receptors in breast cancer.乳腺癌中的雌激素受体
World J Surg. 1977 May;1(3):341-2. doi: 10.1007/BF01556853.
9
[Place of hormone receptor determination in the therapeutic strategy of breast cancer].
Pathol Biol (Paris). 1983 Dec;31(10):809-18.
10
Immunocytochemical assay for estrogen receptor: relationship to outcome of therapy in patients with advanced breast cancer.雌激素受体的免疫细胞化学检测：与晚期乳腺癌患者治疗结果的关系
Cancer Res. 1986 Aug;46(8 Suppl):4241s-4243s.

引用本文的文献

1
Advancing Breast Cancer Heterogeneity Analysis: Insights from Genomics, Transcriptomics and Proteomics at Bulk and Single-Cell Levels.推进乳腺癌异质性分析：来自大量样本和单细胞水平的基因组学、转录组学和蛋白质组学的见解
Cancers (Basel). 2023 Aug 18;15(16):4164. doi: 10.3390/cancers15164164.
2
Association of Enolase-1 with Prognosis and Immune Infiltration in Breast Cancer by Clinical Stage.不同临床分期下烯醇化酶-1与乳腺癌预后及免疫浸润的相关性
J Inflamm Res. 2023 Feb 7;16:493-503. doi: 10.2147/JIR.S396321. eCollection 2023.
3
Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression.
双重 SRC 激酶/微管蛋白前体抑制剂 KX-01 通过 ERα 再表达使 ERα 阴性乳腺癌对他莫昔芬敏感。
Mol Cancer Res. 2017 Nov;15(11):1491-1502. doi: 10.1158/1541-7786.MCR-16-0297-T. Epub 2017 Jul 27.
4
Changes in intrinsic subtype of breast cancer during tumor progression in the same patient.同一患者肿瘤进展过程中乳腺癌内在亚型的变化。
Int J Clin Exp Pathol. 2015 Nov 1;8(11):15184-90. eCollection 2015.
5
Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women.白人女性和黑人女性中雌激素受体表达与乳腺癌特异性死亡风险的定量测量。
Breast Cancer Res. 2013;15(5):R90. doi: 10.1186/bcr3486.
6
Systemic therapy in breast cancer: efficacy and cost utility.乳腺癌的全身治疗：疗效与成本效益
Pharmacoeconomics. 1994 Mar;5(3):198-212. doi: 10.2165/00019053-199405030-00004.
7
Interferon plus tamoxifen treatment for advanced breast cancer: in vivo biologic effects of two growth modulators.干扰素联合他莫昔芬治疗晚期乳腺癌：两种生长调节剂的体内生物学效应
Br J Cancer. 1993 Aug;68(2):352-6. doi: 10.1038/bjc.1993.339.
8
Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies: their correlation with steroid receptors.原发性乳腺癌活检中pS2和总组织蛋白酶D的免疫放射分析检测：它们与类固醇受体的相关性
Br J Cancer. 1994 Mar;69(3):550-4. doi: 10.1038/bjc.1994.100.
9
Long term survival and the prognostic factors of advanced breast cancer patients treated with adreno-oophorectomy.
Breast Cancer Res Treat. 1995;33(1):47-54. doi: 10.1007/BF00666070.
10
Choosing treatment for metastatic breast cancer.转移性乳腺癌的治疗选择。
Br Med J (Clin Res Ed). 1982 Nov 20;285(6353):1444-6. doi: 10.1136/bmj.285.6353.1444-a.